Oncologists Accepting Curative in Boston, MAPage 2
126 verified oncologists in Boston, Massachusetts accept Curative. Profiles cover focus areas including Hematology & Oncology, Medical Oncology, and Melanoma & Cutaneous Oncology. Common hospital affiliations include Massachusetts General Hospital, Mass General Brigham Cancer Institute, and Dana-Farber Cancer Institute.
Jeremy Abramson, MD
Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School
Oncology
Elizabeth Buchbinder, M.D.
Assistant Professor of Medicine, Harvard Medical School
Oncology
Jiping Wang, MD, PHD
Surgical Oncologist, Associate Professor of Surgery, Harvard Medical School
Oncology
Filipa Lynce, M.D.
Assistant Professor of Medicine, Harvard Medical School; Associate Director, Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute
Oncology
Ann Silk, M.D.
Director of the Merkel Cell Carcinoma Center of Excellence; Assistant Professor of Medicine, Harvard Medical School
Oncology
Neil Horowitz, MD
Surgical Director, Gynecologic Oncology; Director, Clinical Research in Gynecologic Oncology; Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School
Oncology
George Demetri, MD
Professor of Medicine, Harvard Medical School; Director, Sarcoma Center, Dana-Farber Cancer Institute; Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Co-Director, Ludwig Center at Dana-Farber/Harvard
Oncology
Leif Ellisen, MD PHD
Professor of Medicine, Harvard Medical School; Program Director, Breast Medical Oncology, Mass General Cancer Center
Oncology
Irene Ghobrial, M.D.
Senior Vice President for Experimental Medicine, Director of the Center for Early Detection and Interception of Blood Cancers, Co-Leader of the Lymphoma/Myeloma Cancer Center Program, Lavine Family Chair for Preventative Cancer Therapies, Director of the Ghobrial Lab, and Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School
Oncology
Brian Wolpin, M.D.
Director, Gastrointestinal Cancer Center; Director, Hale Family Center for Pancreatic Cancer Research
Oncology
Peter Enzinger, MD
Director, Center for Esophageal and Gastric Cancer; Associate Professor of Medicine, Harvard Medical School; Institute Physician
Oncology
Rameen Beroukhim, MD
Associate Professor of Medicine, Harvard Medical School
Oncology
Lecia Sequist, MD
Associate Professor of Medicine, Harvard Medical School; Mary B. Saltonstall Endowed Chair in Oncology, Massachusetts General Hospital Cancer Center
Oncology
Alicia Morgans, MD
Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program
Oncology
Frank Hodi, MD
Professor of Medicine, Harvard Medical School; Director, Melanoma Center and Center for Immuno-Oncology, Dana-Farber Brigham Cancer Center
Oncology
Mary Frates, MD
Professor of Radiology
Oncology
Elad Sharon, M.D.
Director of the Immunotherapy Toxicity Program and a Member of the Faculty of Medicine at Harvard Medical School. From 2011 through August 2023, Dr. Sha
Oncology
William Hahn, MD PHD
Professor of Medicine in the Department of Medical Oncology at Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Ins; Chief Operating and Transformation Officer at the Dana-Farber Cancer Institute.
Oncology
Atul Shinagare, M.D.
Chair, Clinical Operations, Division of Oncoradiology, Brigham Health; Chief of Abdominal Imaging, Brigham Health
Oncology
Carol Benson, MD
Professor of Radiology, Harvard Medical School
Oncology